20-34709442-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_021202.3(TP53INP2):ā€‹c.331A>Gā€‹(p.Thr111Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,536 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 32)
Exomes š‘“: 0.0000027 ( 0 hom. )

Consequence

TP53INP2
NM_021202.3 missense

Scores

5
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.49
Variant links:
Genes affected
TP53INP2 (HGNC:16104): (tumor protein p53 inducible nuclear protein 2) The protein encoded by this gene promotes autophagy and is essential for proper autophagosome formation and processing. In addition, the encoded protein can enhance rDNA transcription by helping in the assembly of the POLR1/RNA polymerase I preinitiation complex. Finally, this protein serves as a transcriptional activator for some genes. [provided by RefSeq, Jul 2016]
NCOA6 (HGNC:15936): (nuclear receptor coactivator 6) The protein encoded by this gene is a transcriptional coactivator that can interact with nuclear hormone receptors to enhance their transcriptional activator functions. This protein has been shown to be involved in the hormone-dependent coactivation of several receptors, including prostanoid, retinoid, vitamin D3, thyroid hormone, and steroid receptors. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jun 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22797528).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TP53INP2NM_021202.3 linkuse as main transcriptc.331A>G p.Thr111Ala missense_variant 4/5 ENST00000374810.8 NP_067025.1 Q8IXH6
TP53INP2NM_001329429.2 linkuse as main transcriptc.331A>G p.Thr111Ala missense_variant 4/5 NP_001316358.1 Q8IXH6
TP53INP2NM_001329430.2 linkuse as main transcriptc.331A>G p.Thr111Ala missense_variant 3/4 NP_001316359.1 Q8IXH6
TP53INP2NM_001329431.2 linkuse as main transcriptc.331A>G p.Thr111Ala missense_variant 4/5 NP_001316360.1 Q8IXH6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TP53INP2ENST00000374810.8 linkuse as main transcriptc.331A>G p.Thr111Ala missense_variant 4/51 NM_021202.3 ENSP00000363943.3 Q8IXH6

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.00000401
AC:
1
AN:
249390
Hom.:
0
AF XY:
0.00000739
AC XY:
1
AN XY:
135328
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000891
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000274
AC:
4
AN:
1461536
Hom.:
0
Cov.:
36
AF XY:
0.00000275
AC XY:
2
AN XY:
727104
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000360
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.000111
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 29, 2024The c.331A>G (p.T111A) alteration is located in exon 4 (coding exon 2) of the TP53INP2 gene. This alteration results from a A to G substitution at nucleotide position 331, causing the threonine (T) at amino acid position 111 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.46
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.030
T;T;T
Eigen
Uncertain
0.30
Eigen_PC
Uncertain
0.29
FATHMM_MKL
Benign
0.69
D
LIST_S2
Benign
0.60
.;T;T
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.23
T;T;T
MetaSVM
Benign
-0.72
T
MutationAssessor
Uncertain
2.6
M;M;.
PrimateAI
Uncertain
0.74
T
PROVEAN
Benign
-1.4
N;N;N
REVEL
Benign
0.089
Sift
Benign
0.060
T;T;D
Sift4G
Benign
0.16
T;T;D
Polyphen
0.99
D;D;.
Vest4
0.38
MutPred
0.29
Loss of glycosylation at T111 (P = 0.069);Loss of glycosylation at T111 (P = 0.069);.;
MVP
0.15
MPC
0.81
ClinPred
0.82
D
GERP RS
4.0
Varity_R
0.15
gMVP
0.54

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1290140609; hg19: chr20-33297246; API